Trademark: 79367537
Word

Status
Pending
Status Code
686
Status Date
Tuesday, September 17, 2024
Serial Number
79367537
Mark Type
2
Filing Date
Tuesday, March 21, 2023
Published for Opposition
Tuesday, September 17, 2024

Trademark Owner History
MILEUTIS LTD - Owner At Publication

Classifications
5 Intramammary and intrauterine veterinary preparations for treating mastitis, mammary infections, uterine infections, myometrium infection and intrauterine infections; intramammary and intrauterine pharmaceutical and medical preparations for human use for treating mastitis, mammary infections, and intrauterine infections; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of mastitis, breast inflammation, mammary infections and mammary inflammation; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of metritis; pharmaceutical preparations, veterinary preparations, and medical preparations for the prevention and treatment of uterine infections; veterinary preparations for increasing milk production and improving feed efficiency, namely for treating gastro-intestinal diseases, anorexia, and for use as growth promoters; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceutical and medical preparations for increasing milk production, namely for treating mastitis, mammary infections, and for involution of the mammary glands; veterinary preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations and medical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations, veterinary preparations and medical preparations for mammary and udder involution; pharmaceutical preparations, veterinary preparations and medical preparations for reduction of somatic cell count in milk, namely for treating mammary and udder inflammations; veterinary preparations, and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms related to infections in lactating animals during the lactation period; veterinary and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in lactating animals, namely for treating mammary pain, mammary infections, and edema; pharmaceutical and medical preparations for the prevention and treatment of lactation-related medical conditions, namely for treating mammary pain, mammary infections, and edema; pharmaceutical preparations, veterinary preparations and medical preparations for the treatment and prevention of infections in poultry, and for use as growth promoters of poultry; pharmaceutical and medical preparations for the prevention or treatment of buccal diseases, disorders and conditions, namely mucositis and buccal infections; pharmaceutical and medical preparations for the prevention or treatment of central, peripherical and neuronal nervous systems diseases; pharmaceutical and medical preparations for the prevention or treatment of gastro-intestinal diseases; pharmaceutical and medical preparations for the prevention or treatment of diseases of the musculo-skeletal system; medical and veterinary preparations to regulate and adapt the mammalian gut microbiome for disease prevention and wellness; pharmaceutical preparations, medical preparations, and veterinary preparations for the treatment of wounds, and damages to the skin and tissues, namely skin and tissue infections; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of dermatological disorders, and skin diseases, related to hyperactive immune response, or allergies; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of immunostimulation and immunomodulation; synthetic and biological peptides for the treatment of immunostimulation, and immunomodulation; pharmaceutical, medical and veterinary preparations to regulate and adapt the mammalian buccal, gastrointestinal and vaginal-vulvar microbiome for disease prevention and wellness
The mark consists of a series of six shaded irregular oval-like shapes, the first appearing in the upper left corner of the mark and consisting of a irregular oval-like shape, to the lower right of which appears two larger irregular oval-like shapes in diagonal-right format, to the lower right of which appears two smaller irregular oval-like shapes in diagonal-right format, and the last appearing on the bottom right corner consisting of an even smaller irregular oval-like shape.

Trademark Events
Apr 13, 2023
Sn Assigned For Sect 66a Appl From Ib
Apr 17, 2023
New Application Office Supplied Data Entered
Dec 16, 2023
Assigned To Examiner
Apr 21, 2023
Application Filing Receipt Mailed
Dec 21, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jun 19, 2024
Teas/Email Correspondence Entered
Jun 19, 2024
Correspondence Received In Law Office
Jun 19, 2024
Teas Response To Office Action Received
Dec 16, 2023
Non-Final Action Written
Dec 17, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Dec 21, 2023
Refusal Processed By Mpu
Jan 8, 2024
Refusal Processed By Ib
Aug 14, 2024
Approved For Pub - Principal Register
Aug 28, 2024
Notification Of Notice Of Publication E-Mailed
Sep 17, 2024
Published For Opposition
Sep 17, 2024
Official Gazette Publication Confirmation E-Mailed
Sep 11, 2024
Notification Of Possible Opposition Sent To Ib
Sep 11, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib

Trademark Alertz updated from USPTO on 2030-01-24